Pancreas-preserving limited duodenal resection: Minimizing morbidity without compromising oncological adequacy

Ajay Sharma; Anand Nagar; Peeyush Varshney; Maunil Tomar; Shashwat Sarin; Rajendra Prasad Choubey; V. K. Kapoor

추천

검색

질문

자료유형: 학술저널

저자정보: Ajay Sharma (Mahatma Gandhi University of Medical Science and Technology) Anand Nagar (Mahatma Gandhi University of Medical Science and Technology) Peeyush Varshney (All India Institute of Medical Sciences) Maunil Tomar (Mahatma Gandhi University of Medical Science and Technology) Shashwat Sarin (Mahatma Gandhi University of Medical Science and Technology) Rajendra Prasad Choubey (Mahatma Gandhi University of Medical Science and Technology) V. K. Kapoor (Mahatma Gandhi University of Medical Science and Technology)

저널정보: 한국간담췌외과학회 Annals of Hepato-Biliary-Pancreatic Surgery 한국간담췌외과학회지 제26권 제2호

발행연도: 2022.5

수록면: 149 - 158 (10page)

이용수

📌

연구주제

📖

연구배경

🔬

연구방법

🏆

연구결과

초록· 키워드

오류제보하기

Backgrounds/Aims: Pancreaticoduodenectomy is the most common procedure for the management of duodenal pathologies. However, it is associated with substantial morbidity and a low risk of mortality. Pancreas-preserving limited duodenal resection (PPLDR) can be performed under specific scenarios. We share our experience with PPLDR and its outcome.
Methods: We retrospectively analyzed a prospectively maintained database of patients undergoing limited duodenal resection in the form of wedge (sleeve) resection or segmental resection of one or more duodenal segments from March 2016 to March 2021 at a tertiary care center in North India.
Results: During the study period, 10 patients (including 9 males) underwent PPLDR. Five of these 10 patients showed primary duodenal or proximal jejunal pathology, while the remaining five had duodenal pathology involving an adjacent organ tumor. Four patients underwent wedge (sleeve) resection, while the remaining six underwent segmental duodenal resection of one or more duodenal segments. Mean hospital stay was 6 days (range, 3–11 days) without 30-day mortality. Morbidity occurred in 4 patients (Grade I–II, n = 3; Grade III, n = 1). All patients were alive and disease-free at the time of last follow-up. The mean follow-up duration was 23 months (range, 2–48 months).
Conclusions: PPLDR is a safe and effective alternative for pancreaticoduodenectomy when selected carefully for specific tumor types and location.

#Duodenal neoplasms #Pancreaticoduodenectomy

참고문헌 (0)

참고문헌 신청

참고문헌이 DBpia에서 서비스 중이라면, [참고문헌 신청]을 통해 등록해보세요

함께 읽어보면 좋을 논문

논문 유사도에 따라 DBpia 가 추천하는 논문입니다. 함께 보면 좋을 연관 논문을 확인해보세요!